Target intelligence / Profile preview

Polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7)

Target: GALNT7
Molecular classification: Enzyme, Glycosyltransferase

Overview

Polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) is an enzyme responsible for the initiation step of mucin-type O-linked glycosylation, catalyzing the transfer of an N-acetylgalactosamine (GalNAc) residue from UDP-GalNAc to the hydroxyl group of serine or threonine residues in target proteins. GALNT7 is a type II transmembrane protein and a member of the GalNAc-transferase family, notable for its exclusive specificity for partially GalNAc-glycosylated acceptor substrates rather than non-glycosylated peptides. If you require updated or more detailed information on disease associations or drug interactions, further literature review or database search is recommended.

Other names: GalNAc-T7GalNAcT7UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7

Biological functions

Initiation of mucin-type O-linked protein glycosylationO-linked oligosaccharide biosynthesisTransfer of N-acetylgalactosamine to serine and threonine residues

Disease associations

Other (disorders of protein glycosylation, but no major established links to cancer, cardiovascular, or other specific diseases in the provided results)

Beyond the preview

Go deeper on Polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7).

Explore the full profile